Checkpoint Therapeutics: Preparing For Cosibelimab's Upcoming PDUFA Date
Checkpoint Therapeutics' cosibelimab shows strong efficacy in treating cSCC. Learn why CKPT stock could see significant gains ...
Investor's Business Daily on MSN15h
Stock Market Today: Chevron Breaks Out, But Biotechs Struggle As Eli Lilly Looks Like Short-Sale Play; Will American Airlines Break Out? (Live Coverage)
Investors continued to see multiple shades of light red as biotechs continued to struggle in the wake of the postelection ...
S&P 500, Nasdaq post biggest drop since late October as stocks edge back from record territory
U.S. stocks ended lower on Thursday, putting a little more daylight between them and the record territory claimed earlier in the week. Investors have been focused on what Donald Trump's second ...